Department of Ophthalmology, Public Ophthalmic Clinical Hospital (SPKSO), Warsaw, Poland.
Department of Ophthalmology, Public Ophthalmic Clinical Hospital (SPKSO), Medical University of Warsaw, Warsaw, Poland.
Med Sci Monit. 2023 Dec 4;29:e941926. doi: 10.12659/MSM.941926.
Visualization of the retinal structure is crucial for understanding the pathophysiology of ophthalmic diseases, as well as for monitoring their course and treatment effects. Until recently, evaluation of the retina at the cellular level was only possible using histological methods, because the available retinal imaging technology had insufficient resolution due to aberrations caused by the optics of the eye. Adaptive optics (AO) technology improved the resolution of optical systems to 2 µm by correcting optical wave-front aberrations, thereby revolutionizing methods for studying eye structures in vivo. Within 25 years of its first application in ophthalmology, AO has been integrated into almost all existing retinal imaging devices, such as the fundus camera (FC), scanning laser ophthalmoscopy (SLO), and optical coherence tomography (OCT). Numerous studies have evaluated individual retinal structures, such as photoreceptors, blood vessels, nerve fibers, ganglion cells, lamina cribrosa, and trabeculum. AO technology has been applied in imaging structures in healthy eyes and in various ocular diseases. This article aims to review the roles of AO imaging in the diagnosis, management, and monitoring of age-related macular degeneration (AMD), diabetic retinopathy (DR), glaucoma, hypertensive retinopathy (HR), central serous chorioretinopathy (CSCR), and inherited retinal diseases (IRDs).
视网膜结构的可视化对于理解眼科疾病的病理生理学以及监测其病程和治疗效果至关重要。直到最近,只有通过组织学方法才能评估细胞水平的视网膜,因为现有的视网膜成像技术由于眼睛光学的像差而分辨率不足。自适应光学 (AO) 技术通过校正光学波前像差将光学系统的分辨率提高到 2 µm,从而彻底改变了活体眼结构的研究方法。在其首次应用于眼科后的 25 年内,AO 已集成到几乎所有现有的视网膜成像设备中,如眼底照相机 (FC)、扫描激光检眼镜 (SLO) 和光学相干断层扫描 (OCT)。许多研究已经评估了单个视网膜结构,如光感受器、血管、神经纤维、节细胞、筛板和小梁。AO 技术已应用于健康眼和各种眼病的结构成像。本文旨在综述 AO 成像在年龄相关性黄斑变性 (AMD)、糖尿病性视网膜病变 (DR)、青光眼、高血压性视网膜病变 (HR)、中心性浆液性脉络膜视网膜病变 (CSCR) 和遗传性视网膜疾病 (IRDs) 的诊断、管理和监测中的作用。